Lung transplantation reduces mortality in patients with end-stage lung disease; however,
only approximately 21% of lungs from potential donor patients undergo transplantation. A …

Lung transplantation is a definitive therapy for the treatment of many end-stage lung
diseases. However, because of donor-related morbidities, only 15% of donor lungs are …

Background Despite the scarcity of donor lungs, most potential donor organs are not offered
by organ procurement organizations or are turned down by transplant centers because no …

Owing to the extremely short supply of donor lungs in Japan, a unique medical consultant
(MC) system was initiated in 2002 to increase the organ availability through intensive …

ABSTRACT Introduction Lung transplantation (LTx) remains the only therapeutic strategy for
patients with incurable lung diseases. However, its use has been severely limited by the …

A proposed standardized algorithm from van Suylen et al (page 2679) may safely increase
rates of transplantation of donation after circulatory death donors in lung transplantation by …

Lung transplantation (LTx) represents a unique lifesaving therapy for patients suffering from
endstage lung disease. Ever since the world's first successful lung transplant was performed …

INTRODUCTION: Brain-dead patients are almost the only source of organs for lung
transplantation, and lungs fall within the area of the least harvested organs. As a result …

Lung transplantation in childhood is a highly specialized clinical practice confined to a few
centers around the world. Organ availability remains an important limiting factor in extending …